Navigation Links
SyntheMed To Present at the AdvaMed 2008 MedTech Conference
Date:9/18/2008

ISELIN, N.J., Sept. 18 /PRNewswire-FirstCall/ -- SyntheMed, Inc. (OTC Bulletin Board: SYMD), a biomaterials company engaged in the development and commercialization of anti-adhesion, drug delivery products and other surgical implants, announced today that it was selected to present at the AdvaMed 2008 MedTech conference being held in Washington, D.C. on September 21-24, 2008. Robert P. Hickey, President and CEO of SyntheMed, is scheduled to present on Wednesday, September 24, at 9:30 a.m. Mr. Hickey's PowerPoint presentation may be viewed at http://www.synthemed.com for thirty days after the presentation.

The purpose of the AdvaMed 2008 MedTech conference is to provide the opportunity for companies in the life sciences sector to present to an elite audience of potential investors, strategic partners and business collaborators. The selection of presenting companies is based on such criteria as: stage of product development, partnering opportunities, potential for licensing technology, intellectual property, timing of next capital raise, and overall appeal to the audience.

About AdvaMed

AdvaMed is the world's largest medical technology trade association representing over 1,600 medical technology innovators, manufacturers of medical devices, diagnostic products and medical information systems.

About SyntheMed, Inc.

SyntheMed, Inc. is a biomaterials company engaged in the development and commercialization of anti-adhesion, drug delivery products, and other surgical implants. The company is primarily focused on the advancement and expansion of product development programs based on its proprietary bioresorbable polymer technology.

Statements in this press release that are not statements of historical fact constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and u
'/>"/>

SOURCE SyntheMed, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. SyntheMed to Present at Canaccord Adams Small-Cap Orthopedics Conference
2. SyntheMed Files Universal Shelf Registration
3. SyntheMed to Present at the Acumen BioFin Conference
4. SyntheMed to Host Symposium on Adhesions in Cardiac Surgery
5. eResearchTechnology, Inc. to Present at the UBS Global Life Sciences Conference on September 23rd, 2008
6. Caliper Life Sciences to Present at UBS Global Life Sciences Conference
7. PharmAthene to Present Data for Protexia(R) and Valortim(R) at HHS PHEMCE Stakeholders Workshop 2008
8. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at UBS Conference
9. BioVex to Present at the UBS Global Life Sciences Conference
10. JD Technologies, LLC Selected by FCT Ingenieurkeramik GmbH to Represent Their High Performance Ceramic Expertise In the United States
11. CryoLife to Present at UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... SAN DIEGO , May 1, 2015 /PRNewswire/ ... biotechnology company engaged in the development of biosimilar ... proteins, announced today that its first quarter 2015 ... 14, 2015, before the open of market. At 8:30 ... conference call to discuss the financial results and ...
(Date:5/1/2015)... May 1, 2015 Albany Molecular Research Inc. ... S. Marth , AMRI,s President and Chief Executive Officer, ... 2015 Health Care Conference on Wednesday, May 13, 2015 ... webcast of the presentation can be accessed at AMRI,s ... The webcast will be archived for 90 days ...
(Date:4/30/2015)... April 30, 2015  Roka Bioscience, Inc. (NASDAQ: ... advanced testing solutions for the detection of foodborne pathogens, ... first quarter of 2015 on May 7, 2015 after ... Bioscience will also host a conference call at 4:30 ... its first quarter financial results. During the conference call, ...
(Date:4/30/2015)... 2015 Nitto Avecia, a leading ... increased capacity and production capability to serve biotechnology ... and service fulfillment continues to drive Nitto Avecia ... throughput capacities. , In Fall 2014, ... process equipment at its Milford, MA facility, which ...
Breaking Biology Technology:Pfenex To Report First Quarter 2015 Results and Provide Business Update on Thursday, May 14, 2015 2AMRI to Present at the Bank of America Merrill Lynch 2015 Health Care Conference 2Roka Bioscience to Report First Quarter 2015 Financial Results On May 7, 2015 2Biotechnology Manufacturer Nitto Avecia Expands Capacity to Meet Client Demand 2
... Pearl Therapeutics, Inc.,a biopharmaceutical company developing treatments ... Colin Reisner, MD, FCCP,FAAAAI to the position of ... Development and Medical Affairs, and Michael Golden,to the ... "We are delighted to welcome Colin and ...
... New Clinical Trial Sites Recently Initiated To Support Ongoing ... Trials-, ... Including Four Phase II Trials in Major Disease Indications-, -Revenues Plus Cash On-Hand ... Advance ...
... HONG KONG, Dec. 20 /Xinhua-PRNewswire-FirstCall/ -- China Technology,Development ... a,provider of clean and renewable energy products and ... announced that it has completed,another step in its ... resources on the principal business of solar energy., ...
Cached Biology Technology:Pearl Therapeutics, Inc. Expands Its Senior Management Team With Top Talent in Clinical Development and Regulatory Affairs 2Pearl Therapeutics, Inc. Expands Its Senior Management Team With Top Talent in Clinical Development and Regulatory Affairs 3Peregrine Pharmaceuticals Remains on Track to Advance its Three Lead Clinical Programs in 2008 2Peregrine Pharmaceuticals Remains on Track to Advance its Three Lead Clinical Programs in 2008 3Peregrine Pharmaceuticals Remains on Track to Advance its Three Lead Clinical Programs in 2008 4Peregrine Pharmaceuticals Remains on Track to Advance its Three Lead Clinical Programs in 2008 5CTDC Announces the Disposal of Non-core Business 2
(Date:4/14/2015)... , April 14, 2015  HYPR Corp. today ... (FIDO ® ) Alliance tm , an industry ... members commit to share technology and collaborate to ... are interoperable, more secure and private, and easier ... identity verification that protects sensitive user information and ...
(Date:4/13/2015)... 2015  higi, a leading cloud-based consumer engagement platform ... engage with their communities around health and wellness, announced ... secure API.  ... affordable, and convenient vehicle to receive validated health information ... The API will allow higi,s trusted partners, on ...
(Date:4/8/2015)... 2015  Infinisource, a leading provider of SaaS-based Human ... a leading supplier of biometric identification and security ... most advanced biometrically-enabled time clock, the companies announced ... is setting a bold, new standard for the ... small and mid-size employer. When connected to the ...
Breaking Biology News(10 mins):HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3
... time in a restful state akin to hibernation rather than ... in cells, new research suggests. And instead of being ... restful period appears to be a programmed step for RNA ... cell division and decide where proteins will work in a ...
... Leuven scientists (VIB/KU Leuven) are using zebrafish as a model ... the mechanism of amyotrophic lateral sclerosis (ALS). As a result, ... for a future ALS treatment. ALS is a progressive degenerative ... Their study has been published in the prestigious journal ...
... have long been appreciated, but now scientists at Duke ... makes mother,s milk better than infant formula in protecting ... in the August issue of the journal Current ... but not infant formula, fosters colonies of microbiotic flora ...
Cached Biology News:To cap or not to cap: Scientists find new RNA phenomenon that challenges dogma 2To cap or not to cap: Scientists find new RNA phenomenon that challenges dogma 3To cap or not to cap: Scientists find new RNA phenomenon that challenges dogma 4Zebra fish point the way towards new therapies for amyotrophic lateral sclerosis 2Breast milk promotes a different gut flora growth than infant formulas 2Breast milk promotes a different gut flora growth than infant formulas 3
...
...
Rabbit polyclonal to XTP4 ( Abpromise for all tested applications). entrezGeneID: 84299 SwissProtID: Q9BRT3...
Chicken polyclonal to QPRT ( Abpromise for all tested applications). Antigen: Synthetic peptide, corresponding to Internal sequence amino acids 123-237 of Human QPRT Entrez Gene ID: 23475 ...
Biology Products: